Goldman Sachs sets FTSE 100 target as it says British underperformance will end

Goldman Sachs believes U.K. stocks will break a period of underperformance and is targeting a gain of about 7% for British blue-chips this year.

Previous post Merck to pay 118% premium to buy cancer drugmaker Harpoon Therapeutics
Next post J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion